Search

Your search keyword '"Montalban A"' showing total 8,941 results

Search Constraints

Start Over You searched for: Author "Montalban A" Remove constraint Author: "Montalban A"
8,941 results on '"Montalban A"'

Search Results

1. Tracing back a second-generation star stripped from Terzan 5 by the Galactic bar

2. Mixed-mode coupling in the Red Clump I. Standard single star models

3. Anomalously low-mass core-He-burning star in NGC 6819 as a post-common-envelope phase product

4. The PLATO Mission

5. Digitized Counterdiabatic Quantum Algorithms for Logistics Scheduling

6. Digital-analog quantum convolutional neural networks for image classification

7. Venetoclax in combination with hypomethylating agents in chronic myelomonocytic leukemia: a propensity score matched multicenter cohort study: MYELODYSPLASTIC NEOPLASM

8. A phase II trial of ipilimumab, nivolumab, or ipilimumab and nivolumab with or without azacitidine in relapsed or refractory myelodysplastic neoplasms

9. Discovery of the local counterpart of disc galaxies at z > 4: The oldest thin disc of the Milky Way using Gaia-RVS

11. Entropy-calibrated stellar modeling: Testing and improving the use of prescriptions for entropy of adiabatic convection

12. K2 results for 'young' $\alpha$-rich stars in the Galaxy

13. Context-Aware Adaptive Prefetching for DASH Streaming over 5G Networks

14. Multi-Layer Monitoring at the Edge for Vehicular Video Streaming: Field Trials

15. Increased EBNA1-specific antibody response in primary-progressive multiple sclerosis

16. Ocrelizumab exposure in relapsing-remitting multiple sclerosis: 10-year analysis of the phase 2 randomized clinical trial and its extension.

17. Outcomes of patients with acute myeloid leukemia and bone marrow fibrosis

19. Liver elastography for risk-assessment of liver toxicity and risk factors for Sinusoidal obstruction syndrome in patients with acute lymphoblastic leukemia receiving inotuzumab ozogamicin

20. Nucleus accumbens D1- and D2-expressing neurons control the balance between feeding and activity-mediated energy expenditure

21. Hematopoietic stem cells with granulo-monocytic differentiation state overcome venetoclax sensitivity in patients with myelodysplastic syndromes

23. The IL-1β inhibitor canakinumab in previously treated lower-risk myelodysplastic syndromes: a phase 2 clinical trial

24. Outcomes of patients with acute myeloid leukemia and bone marrow fibrosis

25. The spark of synchronization in heterogeneous networks of chaotic maps

26. Variational Coherent Quantum Annealing

27. Emergence of chaotic cluster synchronization in heterogeneous networks

28. Physics-Informed Neural Networks for an optimal counterdiabatic quantum computation

29. Efficient DCQO Algorithm within the Impulse Regime for Portfolio Optimization

30. An asteroseismic age estimate of the open cluster NGC 6866 using Kepler and Gaia

31. CAGI, the Critical Assessment of Genome Interpretation, establishes progress and prospects for computational genetic variant interpretation methods

33. Influence of co-mutational patterns in disease phenotype and clinical outcomes of chronic myelomonocytic leukemia

34. Beyond Gaia DR3: Tracing the [$\alpha$/M]-[M/H] bimodality from the inner to the outer Milky Way disc with Gaia-RVS and convolutional neural networks

35. Time evolution of Ce as traced by APOGEE using giant stars observed with the Kepler, TESS and K2 missions

36. Liver elastography for risk-assessment of liver toxicity and risk factors for Sinusoidal obstruction syndrome in patients with acute lymphoblastic leukemia receiving inotuzumab ozogamicin

37. Management of hemolytic transfusion reactions in a patient with chronic myelomonocytic leukemia and rare antibodies: A case report

38. Clinical interrogation of TP53 aberrations and its impact on survival in patients with myeloid neoplasms

39. Digital-analog quantum convolutional neural networks for image classification

40. Time-restricted feeding prevents memory impairments induced by obesogenic diet consumption, via hippocampal thyroid hormone signaling

42. 21434. SUSPENSIÓN DE TERAPIA ANTI-CD20 EN PACIENTES CON ESCLEROSIS MÚLTIPLE MAYORES DE 55 AÑOS

43. 21445. INMUNIDAD HUMORAL PREEXISTENTE CONTRA EL SARAMPIÓN Y EL VIRUS DE LA VARICELA-ZÓSTER EN PACIENTES CON ESCLEROSIS MÚLTIPLE TRAS LA EXPOSICIÓN A TERAPIAS ANTI-CD20: ¿SE PIERDE LA PROTECCIÓN?

44. 21436. NEUMONÍA ORGANIZADA SECUNDARIA ASOCIADA A LA INFECCIÓN POR COVID-19 EN PACIENTES CON ENFERMEDADES DESMIELINIZANTES INFLAMATORIAS DEL SISTEMA NERVIOSO CENTRAL TRATADOS CON TERAPIAS ANTI-CD20

45. 20483. HERPESVIRUS HUMANOS EN LA ESCLEROSIS MÚLTIPLE PRIMARIA PROGRESIVA VERSUS ESCLEROSIS MÚLTIPLE REMITENTE-RECURRENTE

46. 21108. MODELADO DEL RIESGO DE INFECCIÓN EN ESCLEROSIS MÚLTIPLE: EVENTOS INICIALES Y RECURRENTES EN UN ESTUDIO DE COHORTE EMPAREJADO BASADO EN POBLACIÓN EN CATALUÑA

47. 21113. ANÁLISIS LONGITUDINAL DE BIOMARCADORES NEURO-GLIALES SÉRICOS EN MOGAD: ESTUDIO 'MULTIMOGAD'

48. 20485. ÁCIDOS GRASOS DE CADENA CORTA EN PACIENTES DE ESCLEROSIS MÚLTIPLE: ESTUDIO DE SU ASOCIACIÓN CON LA ACTIVIDAD Y LA PROGRESIÓN DE LA ENFERMEDAD

49. 20486. BÚSQUEDA DE NUEVOS BIOMARCADORES A TRAVÉS DEL ESTUDIO DE LOS NIVELES DE PROTEÍNAS INFLAMATORIAS EN MUESTRAS DE SUERO DE PACIENTES DE ESCLEROSIS MÚLTIPLE NO TRATADOS

50. 20946. COMBINACIÓN DE LA PROTEÍNA ÁCIDA FIBRILAR GLIAL Y LA CADENA LIGERA DE LOS NEUROFILAMENTOS EN SUERO PARA PREDECIR EL EMPEORAMIENTO DE LA DISCAPACIDAD Y LA RESPUESTA TERAPÉUTICA EN ESCLEROSIS MÚLTIPLE

Catalog

Books, media, physical & digital resources